More News! Will GSK Bring to Market the First Malaria Treatment in 60 Years?

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week.

  • Sphere Fluidics, based in Cambridge, has received a  €1.6M grant from Eurostars to support the development of its DNA docking tech for genome editing.
  • Orchard Therapeutics extending is its collaboration with Manchester University to include Sanfilippo B Syndrome.

  • GSK has submitted a new drug application to the FDA for its malaria treatment to prevent relapse, which could be the first new treatment in 60 years.
  • Sotio started one of the notable biotechs in the Czech Republic, has a Phase II trial in ovarian cancer.
  • Merck missed its endpoint in a Phase III trial for a third-line gastric cancer treatment.

images via Sainam51, hkhtt hj, kunanon / shutterstock.com

SaveSave

Let's Continue The Conversation

Feel free to send us comments about this article to [email protected] and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.